| Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc |
| Journal website http://www.jocmr.org |
Letter to the Editor
Volume 9, Number 12, December 2017, pages 1029-1031
The Application of Sodium-Glucose Cotransporter 2 Inhibitors to Chronic Kidney Disease Stage 4
Figure

Table
| 1. Reduced blood pressure, arterial stiffness and vascular resistance [15, 16] |
| 2. Decrease in glomerular hyperfiltration [17] |
| 3. Decrease in intraglomerular pressure [18] |
| 4. Reduction in serum uric acid levels [5] |
| 5. Utilization of ketone bodies by failing kidney/heart [19] |
| 6. Improvement in tubulointerstitial hypoxia [20] |
| 7. Increase of erythropoietin [21] |
| 8. Improvement in renal fucntion due to improved cardiac function |